Germán
Bou Arévalo
Mayo Clinic
Rochester, Estados UnidosPublicacións en colaboración con investigadores/as de Mayo Clinic (10)
2016
2003
-
Detection of JNK and p38 activation by flow cytometry analysis
Analytical Biochemistry, Vol. 317, Núm. 2, pp. 147-155
2002
-
CCR5 mediates Fas- and caspase-8 dependent apoptosis of both uninfected and HIV infected primary human CD4 T cells
AIDS, Vol. 16, Núm. 11, pp. 1467-1478
2001
-
Chemokine-receptor activation by env determines the mechanism of death in HIV-infected and uninfected T lymphocytes
Journal of Clinical Investigation, Vol. 107, Núm. 2, pp. 207-215
-
The high level resistance to carbapenemes in Acinetobacter baumannii is a multifactorial problem
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 19, Núm. 7, pp. 336-338
2000
-
Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: High-level carbapenem resistance in A. baumannii is not due solely to the presence of β-lactamases
Journal of Clinical Microbiology, Vol. 38, Núm. 9, pp. 3299-3305
-
Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-lactamase in Acinetobacter baumannii
Antimicrobial Agents and Chemotherapy, Vol. 44, Núm. 2, pp. 428-432
-
OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain
Antimicrobial Agents and Chemotherapy, Vol. 44, Núm. 6, pp. 1556-1561
-
PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii
Clinical Microbiology and Infection, Vol. 6, Núm. 12, pp. 635-643